By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Heat Biologics 

Atlantic Center
119 Washington Avenue, Suite 401
Miami Beach  Florida  33139  U.S.A.
Phone: 305-432-4684 Fax: n/a



Company News
Heat Biologics Completes Patient Enrollment For Randomized Arms Of Its Phase II HS-410 Bladder Cancer Trial 10/8/2015 7:22:33 AM
Heat Biologics To Participate In The Annual Prostate Cancer Foundation Scientific Retreat 10/7/2015 7:39:55 AM
Heat Biologics To Present New Data On Its ComPACT Platform At The CRI-CIMT-EATI-AACR Inaugural International Cancer Immunotherapy Conference 9/16/2015 12:37:51 PM
Heat Biologics To Present At The 17th Annual Global Investment Conference 9/2/2015 8:15:55 AM
Heat Biologics Announces Clinical Trial Combining HS-110 And PD-1 Checkpoint Inhibitor In NSCLC 9/1/2015 8:26:58 AM
Heat Biologics Announces Financial Results For The Second Quarter Ended June 30, 2015 8/13/2015 10:04:25 AM
Heat Biologics Announces Promotions Of Taylor Schreiber, M.D., Ph.D., To Chief Scientific Officer, And Melissa Price, Ph.D., To Vice President Of Product Development 7/27/2015 8:17:51 AM
Heat Biologics To Present At The Cantor Fitzgerald Healthcare Conference 7/1/2015 7:59:43 AM
Heat Biologics Announces Development Of Compact, A Next Generation Combination Immunotherapy Platform 6/15/2015 2:01:22 PM
ASCO15: Heat Biologics To Present Interim Immune Response Data From Ongoing Phase II Trial With HS-110 In Advanced NSCLC At ASCO 5/29/2015 8:45:46 AM